Which act prohibits the reimportation of drugs into the U.S. by anyone other than the manufacturer?

The Prescription Drug Marketing Act of 1987 is the correct choice because it specifically addresses the distribution and marketing practices of prescription drugs in the United States. One of the key provisions of this act is the prohibition of the reimportation of drugs, allowing only the original manufacturers to bring their products back into the U.S. This regulation aims to ensure the safety and efficacy of prescription medications, preventing potential dangers associated with product tampering, alterations, or unknown distribution channels.

Understanding the implications of this act highlights the importance of regulated pharmaceutical practices to safeguard public health. Other legislative measures, while related to different aspects of drug regulation, do not specifically address the issue of reimportation in the same way. The Drug Price Competition Act primarily focuses on the approval process for generic drugs, the Controlled Substances Act regulates the use and distribution of narcotics and controlled substances, and the Anabolic Steroid Control Act of 1990 targets the use of anabolic steroids specifically. Each of these acts has a distinct function but does not cover the reimportation criteria established by the Prescription Drug Marketing Act.